Sumitomo Mitsui Trust Holdings, Inc. Natera, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 935,768 shares of NTRA stock, worth $143 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
935,768
Previous 740,837
26.31%
Holding current value
$143 Million
Previous $117 Million
12.83%
% of portfolio
0.1%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding NTRA
# of Institutions
641Shares Held
120MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$1.88 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$1.03 Billion0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$1.03 Billion0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$678 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $14.8B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...